Drug News

Preferred Medical continues to serve you by staying up to date on industry changes and drug updates that impact you.

Want to recieve drug news updates in your email inbox? Subscribe using the form below!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

The Quest for New Pain Medications: Developments in Non-Opioid Painkillers Offer Hope for Pain Relief without Addiction

The opioid crisis has been a significant public health concern, leading to changes in formulary guidelines regarding opioid use. In response, scientists worldwide are intensifying their efforts to develop non-opioid painkillers. This article explores these efforts and the promising alternatives on the horizon. Emerging Non-Opioid Painkillers In response to the danger of opioid use and …
Read More

Where Have All the Generic Drug Opportunities Gone?

Summary For traditional generic drugs, the current pharmaceutical pipeline is drying up. In an article we published last November, we referenced that 65% of all new drug launches would be specialty drugs by the end of 2023. This is important as new generic drug conversion opportunities will diminish over the next few years. How does …
Read More

Comorbidity and Aging: Direct Impact on Workers’ Compensation Claims

Summary: Comorbidities and aging can have a significant impact on workers’ compensation claims. The aging workforce in the United States, combined with medical inflation and the higher possibility of comorbidity in older workers, is a driving factor in rising claim costs. Workers’ compensation payers can mitigate these challenges by being alert to the complex nature …
Read More

How Workers’ Compensation Payers Can Navigate Specialty Drugs

With advancements in science and technology in the past 30 years, a distinct trend has emerged in the pharmaceutical industry. Pharmaceutical manufacturers have expanded their pipelines to launch new ‘specialty’ drugs designed to treat rare, complex, chronic diseases like cancer, rheumatoid arthritis, and multiple sclerosis. What follows is an overview of the specialty drug market …
Read More

Could There be a Medication that Combats Acute Pain Without Serious Systemic Side Effects Like Addiction?

While the national Opioid Crisis is ongoing, we have made significant progress as a nation in finding alternatives for Workers’ Compensation patients suffering from both Acute and Chronic pain. Another milestone may have been achieved with Vertex’s announcement of a potentially transformative medication for the treatment of pain without serious systemic side effects such as …
Read More

Drug Enforcement Administration (DEA) Mandates Registered Physicians and Healthcare Providers Complete 8-hour CME Training on the Treatment and Management of Patients with Opioid or Other Substance Use Disorders

The Drug Enforcement Administration (DEA) is a U.S. federal law enforcement agency, under the U.S. Department of Justice, charged with combating illicit drug trafficking and distribution within the U.S. Established in 1973, the DEA is 50 years old this year and has been enforcing the controlled substance laws and regulations through a variety of programs …
Read More

FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose

The use of opioid medications is at an all-time low but there is a need to remain vigilant to ensure those patients in need of pain management are not deprived of treatment and are encouraged to obtain the optimum combination of medications and other proven alternative options. As announced previously, the FDA continues to advance …
Read More

FDA Announces New Safety Label Changes for Opioid Pain Medicines

While we have seen a decrease in the use of opioids over the past few years, they are still an important treatment option when prescribed responsibly and appropriately. However, they also have serious risks, including misuse and abuse, addiction, overdose, and death. To help reduce these serious risks, the FDA has developed a vision to …
Read More

Opioid Accountability !?

Drug News from Preferred Medical … Purdue Pharma, the company that manufactures OxyContin, is in the news. Again. On October 21, the Sackler family (company owners) agreed to pay $225 million to resolve their liability under the False Claims Act (FCA). On November 24, their company pled guilty to three felonies – two counts of …
Read More